FDA Officials Discuss Overhauling Agency in NEJM Perspective
"The FDA as a Public Health Agency," New England Journal of Medicine: In the perspective, FDA Commissioner Margaret Hamburg and Joshua Sharfstein, principal deputy commissioner of the agency, provide "a broad overview" of how they plan to "embrace" the agency's mission to protect the public's health. Hamburg and Sharfstein discuss their plans to work with other U.S. agencies, such as NIH, CDC and CMS, as well as challenges posed by globalization. In addition, they write that they will work to improve transparency at FDA (Hamburg/Sharfstein, NEJM, 5/26).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.